Nike Heads for Biggest Quarterly Drop Since 2008

image

(Bloomberg) — In an industry pressured by soaring inflation, Nike Inc. is suffering more than most as its exposure to the fallout from the war in Ukraine and supply-chain issues put its shares on track for their worst quarter since 2008.

The stock is down 22% this year, double the pace of the 11% decline in the S&P 500 consumer discretionary index, as decades-high inflation hurts shoppers’ sentiment and wallets. The company will report fiscal third-quarter earnings after markets close on Monday.

Production shortfalls and transport delays in particular make for a “tough-to-predict” report, according to Morgan Stanley analyst Kimberly Greenberger. Even if the company delivers a beat and raise quarter, uncertainty around the drivers of underperformance in China, potential impacts from Russia’s invasion of Ukraine and inventory levels could keep the stock range bound.

Read more: Nike’s Supply Chain a Key Focus in Quarterly Report: Preview

“It’s unlikely 3Q results resolve these lingering debates, delaying any material valuation re-rating to the 4Q earnings report (in June) or beyond,” Greenberger wrote in a note last week. Nike shares fell 0.8% on Monday.

BofA Securities analyst Lorraine Hutchinson recently lowered her earnings per share estimates for fiscal 2022 and 2023, citing exposure to Russia and eastern Europe as well as Covid-related volatility in China.

Bloomberg Intelligence: Russia Risk May Threaten Nike’s $11 Billion of Sales in EMEA

Still, analysts remain largely positive on Nike, which has 28 buy ratings, 7 holds and 1 sell, according to data compiled by Bloomberg. Even though several analysts have trimmed their price targets ahead of earnings, the average analyst target still implies return potential of 29% for the next 12 months.

“We see a compelling buying opportunity for one of our favorite long-term growth stories,” Truist Securities analyst Beth Reed wrote in a note last week.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More